课题基金 / 基金详情

Immunological study for osteoarthritis focusing on T cells.

Immunological study for osteoarthritis focusing on T cells.
以 T 细胞为重点的骨关节炎免疫学研究。
批准号:
11671461
负责人:
NAKAMURA Hiroshi
金额:
$1.73万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

NAKAMURA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, we investigated immune mechanism in the pathogenesis in osteoarthritis (OA) focusing on T cell.1) Hitological study showed infiltration of CD3 positive T cells into the synovial tissues from OA patients. Clonal infiltration of these T cells was proven by the SSCP analysis, and some of the cells had shared CDR3 region (LEFG, VPTGVG, LRGS) in TCR Vβ chain.2) Osteopontin (OPN) is one of chondrocyte derived protein. Autoantibody against OPN was detected in 9.5% of sera from OA patients and 15% of rheumatoid arthritis (RA) patients.3) YKL-39, a cartilage-related protein was expressed as a fusion protein using E-coll system. Autoantibody against human recombinant YKL-39 (hrYKL-39) was detected in 11.1% of sera from OA patients and 11.8% of RA patients. PBL response against hrYKL-39 was studied in the patients whose sera was positive for the protein. PBL reacted with hrYKL-39 in 46% of OA patients, it did in only 17 % of RA patients. From the epitope analysis, one third of the N-terminal fragment had strongest antigenicity.4) Cartilage intermediate layer protein (CILP), which is secreted in aged cartilage, was expressed as a recombinant protein (hrCILP). Autoantibldy against hrCILP was detected 10.5% of OA patients and 7.9% of RA patients. The strongest antigenicity was revealed in fragment ranging from 422 to 555 amino residue of CILP protein. Moreover, hrCILP induced chronic arthritis in mice.5) When chondrocytes were co-cultured with self PBL, PBL from OA patients showed higher proliferative response than PBL from RA patients by 5.2 times, This proliferative response was inhibited by anti CD4, CD8, HLA class I and HLA class II antibodies.In conclusion, autoantibody against some proteins derived from cartilage was detected. There was clonality in T cells infiltrating into synovial tissue in OA.Taken together, T cell mediated immune response might be involved in the pathogenesis of OA.The therapeutic strategy focusing T cells was suggested.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
Hirohata S et al: "Bone marrow CD34+progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals."Rheumatol Int. 19. 153-159 (2000)
Hirohata S 等人:“类风湿性关节炎患者的骨髓 CD34 祖细胞支持健康个体外周血 B 细胞的自发转化。”Rheumatol Int.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kitagawa M et al: "Interferon-ganmma enhances interlekin-12 production in rheumatoid synovial cells via CD40-CD154 dependent and indepent RA pathways."J Rheumatol. (In press).
Kitakawa M 等人:“干扰素-ganmma 通过 CD40-CD154 依赖和独立的 RA 途径增强类风湿滑膜细胞中 interlekin-12 的产生。”J Rheumatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuruha J et al: "Implication of cartilage intermediate layer protein (CILP) in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis."Arthritis Rheum. (In press).
Tsuruha J 等人:“软骨中间层蛋白 (CILP) 对骨关节炎和类风湿性关节炎患者软骨破坏的影响。”关节炎大黄。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuruha J et al: "Implication of cartilage intermediate layer protein(CILP) in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis."Arthritis Rheum. (In press).
Tsuruha J 等人:“软骨中间层蛋白 (CILP) 对骨关节炎和类风湿性关节炎患者软骨破坏的影响。”关节炎大黄。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    Basic research about bone regeneration and oral implant for craniofacial defect patients
    • 批准号:
      23593054
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      NAKAMURA Hiroshi
    • 依托单位:
    Research on Data Resident Computing
    • 批准号:
      22650008
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.2万
    • 财政年份:
      2010
    • 负责人:
      NAKAMURA Hiroshi
    • 依托单位:
    Matrix metalloproteinase-3 in a stable form, a novel medicament for pulpitis
    • 批准号:
      21390512
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2009
    • 负责人:
      NAKAMURA Hiroshi
    • 依托单位:
    Study of Crude Bone Morphogenetic Protein(BMP)for use as Pulp-Capping Material
    • 批准号:
      18592103
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.07万
    • 财政年份:
      2006
    • 负责人:
      NAKAMURA Hiroshi
    • 依托单位:
    海外基金